Crossmark

Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer

Crossref DOI link: https://doi.org/10.1007/s00262-022-03157-w

Published Online: 2022-01-31

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Hong Kyu

Ji, Hyeong-Jin

Shin, Sang-Kyung

Koo, Jihye

Kim, Tae Hun

Kim, Cho-Won

Seong, Yeon Hee

Park, Jun-Eui

Choi, Kyung-Chul https://orcid.org/0000-0002-1925-1198
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2020R1A2C2006060)
License Information

Text and Data Mining valid from 2022-01-31

Version of Record valid from 2022-01-31
More Information

Article History

Received: 24 August 2021

Accepted: 16 January 2022

First Online: 31 January 2022

Declarations

:

: Jun-Eui Park, Jihye Koo, and Tae Hun Kim are current employees of Autotelic Bio, Inc. All other authors do not have any conflicts of interest to declare.

: All procedures involving experimental animals complied with regulations for the care and use of laboratory animals of the animal ethics committee of Chungbuk National University (CBNUA-1235–18-01).

: Not applicable.

: All authors agreed to publish these results and data for publication.

Document is current

Any future updates will be listed below